- Home
- PRPH vs MBRX Comparison
PRPH vs MBRX Comparison
Compare PRPH & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- MBRX
- Stock Information
- Founded
- PRPH 1989
- MBRX 2015
- Country
- PRPH United States
- MBRX United States
- Employees
- PRPH N/A
- MBRX N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- MBRX Health Care
- Exchange
- PRPH Nasdaq
- MBRX Nasdaq
- Market Cap
- PRPH 15.2M
- MBRX 14.7M
- IPO Year
- PRPH 1997
- MBRX 2016
- Fundamental
- Price
- PRPH $0.36
- MBRX $0.67
- Analyst Decision
- PRPH
- MBRX Strong Buy
- Analyst Count
- PRPH 0
- MBRX 2
- Target Price
- PRPH N/A
- MBRX $6.00
- AVG Volume (30 Days)
- PRPH 1.9M
- MBRX 1.0M
- Earning Date
- PRPH 05-20-2025
- MBRX 05-13-2025
- Dividend Yield
- PRPH N/A
- MBRX N/A
- EPS Growth
- PRPH N/A
- MBRX N/A
- EPS
- PRPH N/A
- MBRX N/A
- Revenue
- PRPH $5,845,000.00
- MBRX N/A
- Revenue This Year
- PRPH $221.82
- MBRX N/A
- Revenue Next Year
- PRPH N/A
- MBRX N/A
- P/E Ratio
- PRPH N/A
- MBRX N/A
- Revenue Growth
- PRPH N/A
- MBRX N/A
- 52 Week Low
- PRPH $0.22
- MBRX $0.40
- 52 Week High
- PRPH $4.94
- MBRX $4.90
- Technical
- Relative Strength Index (RSI)
- PRPH 52.22
- MBRX 29.72
- Support Level
- PRPH $0.23
- MBRX $0.62
- Resistance Level
- PRPH $0.40
- MBRX $0.93
- Average True Range (ATR)
- PRPH 0.05
- MBRX 0.07
- MACD
- PRPH 0.00
- MBRX -0.03
- Stochastic Oscillator
- PRPH 64.00
- MBRX 14.06
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.